- Report
- August 2022
- 120 Pages
Global
From €4325EUR$4,500USD£3,709GBP
- Report
- April 2023
- 116 Pages
Global
From €4325EUR$4,500USD£3,709GBP
- Report
- January 2023
- 203 Pages
Global
From €3460EUR$3,600USD£2,967GBP
- Report
- July 2023
- 101 Pages
China
From €1730EUR$1,800USD£1,484GBP
- Report
- July 2023
- 133 Pages
China
From €1730EUR$1,800USD£1,484GBP
- Report
- April 2023
- 156 Pages
Global
€4806EUR$5,000USD£4,121GBP
- Report
- April 2023
- 114 Pages
Global
€3364EUR$3,500USD£2,885GBP
- Report
- April 2023
- 109 Pages
Global
€3364EUR$3,500USD£2,885GBP
- Report
- October 2023
- 93 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- May 2024
- 50 Pages
Global
From €2547EUR$2,650USD£2,184GBP
- Report
- May 2024
- 50 Pages
Global
From €2547EUR$2,650USD£2,184GBP
- Report
- May 2024
- 50 Pages
Global
From €2547EUR$2,650USD£2,184GBP
- Report
- May 2024
- 50 Pages
Global
From €2547EUR$2,650USD£2,184GBP
- Report
- May 2024
- 50 Pages
Global
From €2547EUR$2,650USD£2,184GBP
- Report
- May 2024
- 50 Pages
Global
From €2547EUR$2,650USD£2,184GBP
- Report
- July 2023
- 285 Pages
China
From €3845EUR$4,000USD£3,297GBP
- Report
- March 2022
Global
From €4662EUR$4,850USD£3,997GBP
- Report
- March 2021
Japan, United States, ... Japan, United States, Europe
From €913EUR$950USD£783GBP
- Report
- February 2020
Japan, United States, ... Japan, United States, Europe
From €913EUR$950USD£783GBP
- Report
- April 2023
- 160 Pages
Global
From €5766EUR$5,999USD£4,945GBP
Theophylline is a respiratory drug used to treat asthma, bronchitis, and other respiratory conditions. It is a bronchodilator, meaning it helps to open up the airways in the lungs, allowing for easier breathing. It is available in both oral and intravenous forms, and is often used in combination with other medications. Theophylline is also used to treat chronic obstructive pulmonary disease (COPD).
Theophylline is a generic drug, meaning it is available in a variety of brands. It is also available in combination with other drugs, such as corticosteroids, to treat more severe cases of asthma and COPD.
Theophylline is a widely used drug in the respiratory market, and is often prescribed as a first-line treatment for asthma and COPD. It is also used to treat other respiratory conditions, such as chronic bronchitis and emphysema.
Companies in the Theophylline market include GlaxoSmithKline, Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more